- Enocitabine
-
- $48.00 / 1mg
-
2024-11-19
- CAS:55726-47-1
- Min. Order:
- Purity: 98.02%
- Supply Ability: 10g
- Enocitabine
-
- $0.00 / 1g
-
2020-07-22
- CAS:55726-47-1
- Min. Order: 1g
- Purity: 99.0%
- Supply Ability: 50kg/month
- Enocitabine
-
- $1.00 / 1KG
-
2019-12-25
- CAS:55726-47-1
- Min. Order: 1IU
- Purity: 99%
- Supply Ability: 100kg
|
| | Enocitabine Basic information |
| Product Name: | Enocitabine | | Synonyms: | N-(1-BETA-D-ARABINOFURANOSYL-1,2-DIHYDRO-2-OXO-4-PYRIMIDINYL)DOCOSANAMIDE;NSC-239336;SUNRABIN;BEHENOYLCYTOSINE ARABINOSIDE;BH-AC;ENOCITABINE;n-(1-beta-d-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-docosanamid;n(sup4)-behenoyl-1-beta-d-arabinofuranosylcytosine | | CAS: | 55726-47-1 | | MF: | C31H55N3O6 | | MW: | 565.78 | | EINECS: | 1312995-182-4 | | Product Categories: | Intermediates & Fine Chemicals;Pharmaceuticals | | Mol File: | 55726-47-1.mol |  |
| | Enocitabine Chemical Properties |
| Melting point | 141-142°C | | alpha | D +70° (c = 1 in THF, 22°) | | Boiling point | 630.87°C (rough estimate) | | density | 1.0967 (rough estimate) | | refractive index | 1.7800 (estimate) | | storage temp. | Keep in dark place,Sealed in dry,Store in freezer, under -20°C | | solubility | DMSO (Slightly, Heated), Methanol (Slightly, Heated), THF (Slightly, Heated, Soncited) | | pka | 10.14±0.20(Predicted) | | form | Solid | | color | White to Off-White | | CAS DataBase Reference | 55726-47-1(CAS DataBase Reference) |
| | Enocitabine Usage And Synthesis |
| Description | Enocitabine (NSC-239336, BHAC) is an antileukemic agent closely related to cytarabine. It appears
more resistant to deamination than cytarabine, thus allowing greater in vivo
phosphorylation into an active cytotoxic metabolite. Enocitabine is lipophilic, but the drug does not enter the cerebrospinal fluid and is concentrated in the bone marrow and red blood cells. It can be administered orally and appears to be more effective than the parent compound in preclinical models. | | Chemical Properties | Crystalline Solid | | Originator | Asahi (Japan) | | Uses | An antineoplastic. A derivative of Cytarabine. | | Definition | ChEBI: Enocitabine is an organic molecular entity. | | Brand name | SUNRABIN |
| | Enocitabine Preparation Products And Raw materials |
|